Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis
| Autor: | Jo Waller, Zeev Rosberger, Navdeep Kaur, Emily McBride, Rona Moss-Morris, Laura A.V. Marlow, Ovidiu Tatar, Lauren Rockliffe, Kristina Wade |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Emotions Uterine Cervical Neoplasms Alphapapillomavirus Cervical cancer screening 03 medical and health sciences 0302 clinical medicine Internal medicine Humans Mass Screening Medicine 030212 general & internal medicine Human papillomavirus Papillomaviridae Early Detection of Cancer 030505 public health Cervical screening business.industry Papillomavirus Infections virus diseases Psychiatry and Mental health Clinical Psychology Meta-analysis Female 0305 other medical science business |
| Zdroj: | McBride, E, Tatar, O, Rosberger, Z, Rockliffe, L, Marlow, L A V, Moss-Morris, R, Kaur, N, Wade, K & Waller, J 2020, ' Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis ', Health psychology review . https://doi.org/10.1080/17437199.2020.1762106 |
| Popis: | Tens-of-millions of women every year test positive for human papillomavirus (HPV) at routine cervical screening. We performed a mixed-methods systematic review using a results-based convergent design to provide the first comprehensive overview of emotional response to testing positive for HPV (HPV+). We mapped our findings using the cognitive behavioural framework. Six electronic databases were searched from inception to 09-Nov-2019 and 33 papers were included. Random-effects meta-analyses revealed that HPV+ women with abnormal or normal cytology displayed higher short-term anxiety than those with normal results (MD on State-Trait Anxiety Inventory = 7.6, 95% CI: 4.59-10.60 and MD = 6.33, CI: 1.31-11.35, respectively); there were no long-term differences. Psychological distress (general/sexual/test-specific) was higher in HPV+ women with abnormal cytology in the short-term and long-term (SMD = 0.68, CI: 0.32-1.03 and SMD = 0.42, CI: 0.05-0.80, respectively). Testing HPV+ was also related to disgust/shame, surprise and fear about cancer. Broadly, adverse response related to eight cognitive constructs (low control, confusion, cancer-related concerns, relationship concerns, sexual concerns, uncertainty, stigma, low trust) and six behavioural constructs (relationship problems, social impact, non-disclosure of results, idiosyncratic prevention, indirect clinical interaction, changes to sexual practice). Almost exclusive use of observational and qualitative designs limited inferences of causality and conclusions regarding clinical significance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|